(Q27729457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

Aertgeerts K

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

De Bondt HL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

De Ranter CJ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 October 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

Nature structural biology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

891-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

Protein inhibitors of proteinases

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Serpin tertiary structure transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Ovalbumin and angiotensinogen lack serpin S-R conformational change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Structural basis of latency in plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Crystal structure of ovalbumin as a model for the reactive centre of serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Proteolytically cleaved mutant antithrombin-Hamilton has high stability to denaturation characteristic of wild type inhibitor serpins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Mobile reactive centre of serpins and the control of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Biological implications of a 3 A structure of dimeric antithrombin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Crystallization and X-ray diffraction data of the cleaved form of plasminogen activator inhibitor-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

A model of the reactive form of plasminogen activator inhibitor-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Purification and characterization of active and stable recombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coli.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Conformational Studies on Plasminogen Activator Inhibitor (PAI-1) in Active, Latent, Substrate, and Cleaved Forms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

The role of conformational change in serpin structure and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Kinetic characterization of the proteinase binding defect in a reactive site variant of the serpin, antithrombin. Role of the P1' residue in transition-state stabilization of antithrombin-proteinase complex formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Improved methods for building protein models in electron density maps and the location of errors in these models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Crystallographic R factor refinement by molecular dynamics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

Improved Fourier coefficients for maps using phases from partial structures with errors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSB1095-891

31 March 2020

Identifiers

DOI

10.1038/NSB1095-891

2 references

Consolidated OpenCitations Corpus – April 2017

3733769

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7552714%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

3733769

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3733769